Fermenta Biotech Limited (BOM:506414)
India · Delayed Price · Currency is INR 369.50
-25.50 (-6.46%)
At close: Jul 7, 2026
Fermenta Biotech Market Cap
Fermenta Biotech has a market cap or net worth of 10.87 billion as of July 7, 2026. Its market cap has increased by 8.36% in one year.
Market Cap
10.87B
Enterprise Value
11.54B
Revenue
5.25B
Ranking
n/a
PE Ratio
15.08
Stock Price
369.50
Market Cap Chart
Since July 31, 1998, Fermenta Biotech's market cap has increased from 335.80M to 10.87B, an increase of 3,138.47%. That is a compound annual growth rate of 13.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 10.87B | 6.18% |
| Dec 31, 2025 | 10.24B | -4.38% |
| Dec 31, 2024 | 10.71B | 129.56% |
| Dec 29, 2023 | 4.67B | -6.88% |
| Dec 30, 2022 | 5.01B | -40.13% |
| Dec 31, 2021 | 8.37B | -8.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fredun Pharmaceuticals | 14.27B |
| Shukra Pharmaceuticals | 13.93B |
| Syncom Formulations (India) | 13.38B |
| TTK Healthcare | 13.00B |
| Lincoln Pharmaceuticals | 12.42B |
| Wanbury | 10.02B |
| Bharat Parenterals | 9.54B |
| Sudarshan Pharma Industries | 9.50B |